Alnylam Pharmaceuticals
Priya Govekar is a seasoned regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as Senior Director and Global Regulatory Franchise Lead at Alnylam Pharmaceuticals since October 2021, Priya has previously held senior roles at AstraZeneca from July 2015 to September 2021, and at Amgen from August 2012 to July 2015. Priya's career also includes a tenure as Senior Manager in Global Regulatory Affairs at UCB from May 2006 to August 2012. Academic qualifications encompass a BSc Hons in Molecular Biology and Genetics from the University of East Anglia and a Master of Science in Medical Biotechnology from the University of Westminster.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.